Associate Professor of Oncology at Washington University School of Medicine, St Louis, MO (USA)
Foluso Ademuyiwa MD MPH MSCI is a medical oncologist and Associate Professor at Washington University School of Medicine (WUSM) in St Louis. Dr. Ademuyiwa earned a medical degree from the University of Ibadan in Nigeria, completed a residency in Internal Medicine/Pediatrics at Bridgeport Hospital-Yale New Haven Health, and fellowship in Hematology/Oncology at Indiana University. Her research is focused on designing and conducting innovative clinical trials in triple-negative breast cancer (TNBC), using ctDNA to predict outcomes in TNBC, and in racial disparities in breast cancer. In recognition of her clinical work, she has consistently been named as a “Best Doctor” in St. Louis for 2015 – 2020, Castle Connolly Top Doctor in 2021, and has been named as one of the 27 Top Breast Cancer Oncologists by Forbes in 2017.
Interest/specialization: Breast Cancer
Karen Anderson MD PhD
Professor, Biodesign Institute at Arizona State University | Associate Professor of Medicine at Mayo Clinic Arizona
Karen Anderson is a professor at the Biodesign Institute at Arizona State University’s Virginia G. Piper Center for Personalized Diagnostics and ASU’s School of Life Sciences. She is also a medical oncologist and an associate professor of medicine at Mayo Clinic Arizona. She is focused on understanding how the immune response can be used to detect and alter cancer development. To create effective cancer immunotherapy, Anderson’s team identifies target antigens and pushes the scientific understanding of the mechanisms of immune regulation that limit effective immunotherapy.
Interest/specialization: Medical Oncology
Ira J. Bleiweiss MD
Director, Division of Breast Pathology, Attending Pathologist Hospital at University of Pennsylvania | Professor of Pathology and Lab Medicine Perelman School of Medicine at University of Pennsylvania
Dr. Bleiweiss is an internationally known surgical pathologist specializing in breast pathology. He is a Professor of Pathology at Perelman School of Medicine of the University of Pennsylvania in Philadelphia and Attending Pathologist at the Hospital of the University of Pennsylvania, where he also directs the Division of Breast Pathology. He previously held the same positions at Icahn School of Medicine at Mount Sinai in New York and The Mount Sinai Medical Center where he was also Director of Anatomic Pathology and Chief of Surgical Pathology. A graduate of the University of Pennsylvania and St. George’s University School of Medicine, he performed his residency in Pathology at Mount Sinai Medical Center followed by fellowships in surgical and anatomic pathology at Mount Sinai and Memorial Sloan Kettering Cancer Center.
He has been an active participant in national clinical breast cancer trials as he led the Breast Pathology Cadre of Cancer and Leukemia Group B. Dr. Bleiweiss has published numerous articles and book chapters, as well as a textbook on radiologic/pathologic correlation in breast core biopsies, serves as a reviewer and editorial board member for several peer-reviewed journals, and is an active member of many pathologies and multidisciplinary breast cancer-focused societies.
Interest/specialization: Breast pathology, breast cancer subclassification and prognostication, breast core biopsy interpretation, and radiologic correlation.
Lily Gutnik MD MPH
Breast Surgical Oncology Fellow Department of Surgery at Duke University Medical Center
Dr. Gutnik is currently completing a Breast Surgical Oncology fellowship at Duke University School of Medicine and will be joining the faculty at the University of Alabama (UAB) Department of Surgery and the O’Neal Comprehensive Cancer Center in November 2021; where she will also serve as the Assistant Program Director of Global Surgery. Her longstanding research passion has revolved around the impact of breast cancer screening and early detection in low-resource settings.
She was previously a Fulbright and Fogarty Fellow in Lilongwe, Malawi where she established and evaluated the efficacy of Malawi’s first breast cancer screening initiative by activating laywomen to become trained breast health workers. In addition, she serves in an advisory role for three international NGOs: (i) Know Your Lemons, which focuses on education and awareness materials; (ii) Discovering Hands, which focuses on training blind women to become clinical breast examiners; and (iii) Swasti, which provides impoverished people in India with primary care and cancer screening services. Moreover, she is currently collaborating on breast cancer projects in Tanzania, Malawi, and Nigeria.
Interest/specialization: Breast Cancer
Lisa Jacobs MD MSPH
Associate Professor of Surgery and Oncology Division Chief of Breast Surgery at Johns Hopkins University
Dr. Jacobs specializes in melanoma and breast cancer. Her initial practice was at the University of Missouri at the Ellis Fischel State Cancer Center, which is the designated cancer center for the state. Since joining Johns Hopkins in 2004, she has taken a leadership role regarding clinical research trials for the surgical division of the Johns Hopkins Breast Center. In 2012, Dr. Jacobs established a new breast center at Howard County General Hospital. As director of that program, she treats patients with all types of breast disease and melanoma. Dr. Jacobs has a clinical interest in the treatment of early-stage melanoma. She has worked closely with dermatologists and medical oncologists at Johns Hopkins University and Howard County General Hospital to improve awareness and care of melanoma patients by participating in educational programs and clinical research trials.
Breast cancer care has been a focus of Dr. Jacobs’ clinical practice since finishing her surgical oncology fellowship. Her primary clinical interest is in improving the overall quality of life for breast cancer patients. To achieve that goal, she has initiated research programs in lymphedema and oncoplastic surgery, which attempts to increase the number of women eligible for breast preservation by combining lumpectomy with plastic surgery techniques to reshape the breast. In addition, she has research funding to investigate a new device that may reduce the number of surgeries required to achieve breast preservation.
Interest/specialization: Research to reduce the burden of disease, breast cancer, and melanoma.
Carol Marquez MD FACR
Clinical Professor, Radiation Oncology at Stanford University
After completing medical school and a medical internship at UCSF, I also completed my radiation oncology residency at UCSF. I then did a one-year fellowship at Stanford University in radiosensitizers and radioimmunotherapy. Staying on the west coast, I joined the faculty at Oregon Health and Sciences where I remained for 23 years. I elected to return home to the Bay Area and joined the faculty at Stanford University in 2015. I currently am the medical director of the South Bay Cancer Center, Stanford’s free-standing center in San Jose.
Interest/specialization: Breast and radiation therapy.
Jennifer Plichta MD MS FACS
Director, Breast Risk Assessment Clinic at Duke Cancer Institute | Associate Professor, Departments of Surgery and Population Health Sciences
Dr. Jennifer Plichta is an Associate Professor of Surgery & Population Health Sciences at Duke University. She serves as the Director of the Breast Risk Assessment Clinic in the Duke Cancer Institute, where she cares for patients with breast cancer, benign breast problems, and those with an increased risk of breast cancer. Her clinical interests include establishing routine breast cancer risk assessment for women undergoing annual mammography and creating personalized management strategies for those found to be “high risk”.
Dr. Plichta’s research focuses on identifying and managing women with risk factors for breast cancer, including those with genetic mutations, such as BRCA, abnormal breast biopsies, and a family history of breast cancer. She is also studying how breast cancer staging can be used to improve patient care and education. However, her dedication to breast cancer extends beyond her clinical and research interests. She also enjoys educating the community about breast cancer and helping to raise money for breast cancer research and education. She is the creator and primary coordinator of Duke’s free, annual breast education day for the community, “What’s best for breasts?”.
Interest/specialization: Breast surgery, breast cancer, breast cancer risk, and germline genetic mutations that predispose patients to breast cancer.
Cesar A. Santa-Maria MD MSCI
Assistant Professor of Oncology, Women’s Malignancy Disease Group | The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cesar A. Santa-Maria, MD MSCI, is an Assistant Professor at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. His clinical area of expertise is caring for patients with breast cancer. His research focus is also on patients with breast cancer, and he has a special interest in developing new treatments using immunotherapy as well as investigating biological changes related to immunotherapy that may help identify responders or improve treatment strategies. His work had been published in peer-reviewed journals, and he had received numerous awards for his work including from the National Institute of Health, the foundational and institutional grants.
Interest/specialization: Breast cancer and immunotherapy.
Michelle Specht MD
Visiting Surgeon at Massachusetts General Hospital | Associated Professor at Harvard Medical School
Dr. Michelle Specht is a graduate of Wesleyan University and Cornell University Medical College. She completed her surgical training at New York Hospital-Cornell University Medical Center. She spent two years during her surgical training as a research fellow. Following her residency, Dr. Specht completed a fellowship in Breast Surgery at Memorial Sloan Kettering Cancer Center. Since 2004, Dr. Specht has been on staff at Massachusetts General Hospital and Newton Wellesley Hospital and on the faculty of Harvard Medical School.
Interest/specialization: Breast cancer and surgical oncology.
Alphonse Taghian MD PhD FASTRO
Professor of Radiation Oncology at Harvard Medical School | Director, Lymphedema Research Program at Massachusetts General Hospital
Dr. Alphonse Taghian, Professor of Radiation Oncology at Harvard Medical School, earned his Medical Degree from Alexandria University in Egypt. He completed his residency in Radiation Oncology in France, after which he pursued clinical and research fellowships at Gustave-Roussy Institut, Paris.
After obtaining his Ph.D. in Radiobiology from Paris XI University, Dr. Taghian was appointed as staff in the Department of Radiation Oncology at Massachusetts General Hospital. He is now the Director of the Lymphedema Research Program and Co-Director of the Breast Cancer Research Program at Massachusetts General Hospital.
An internationally recognized leader in breast radiation oncology, in particular in the field of Accelerated Partial Breast Irradiation (APBI), Dr. Taghian has published more than 250 peer-reviewed articles, general reviews, and chapters. He has edited two books. He was awarded several NIH grants totaling around $2.7 Million for research in breast cancer-related lymphedema.
Interest/specialization: Screening and early intervention for lymphedema, methods to minimize cardiac exposure to radiation, accelerated partial breast irradiation, the impact of radiation on breast reconstruction, and indications for post-mastectomy radiation.